Testing a malaria vaccine in healthy adults
Treatments studied
Part of Infections clinical trials.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old
- You are generally healthy
- You have never had malaria and have not spent more than 6 months in a malaria-endemic area in the last 5 years
- You are not pregnant, breastfeeding, or planning to become pregnant
- You have not had a splenectomy, sickle cell disease or trait, or severe mosquito-bite allergies
- You are not taking certain medications that could interfere with the study medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new malaria vaccine to see if it is safe and how the body responds. It involves healthy adults in Burkina Faso who will be monitored closely after vaccination.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults living in Burkina Faso. If you qualify, the vaccine is given to see if it can protect you from malaria.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.